BiosanaPharma Sees Success In Omalizumab Trial

Phase I Study Shows Favorable Comparison To Novartis' Xolair Brand

 
• By David Wallace
  
84
The Omalizumab Trial Involved 84 Volunteers • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products